ResMed Inc. (FRA:RMEA)

Market Cap	32.14B
Revenue (ttm)	4.48B
Net Income (ttm)	1.23B
Shares Out	n/a
EPS (ttm)	8.33
PE Ratio	26.23
Forward PE	22.94
Dividend	0.20 (0.96%)
Ex-Dividend Date	Nov 12, 2025

Volume	n/a
Average Volume	5
Open	21.60
Previous Close	21.00
Day's Range	21.60 - 21.60
52-Week Range	17.90 - 24.60
Beta	n/a
RSI	43.87
Earnings Date	Jan 22, 2026

About ResMed

ResMed Inc. develops, manufactures, distributes, and markets medical devices and cloud-based software applications to diagnose, treat, and manage respiratory disorders in the United States and internationally. The company operates in two segments, Sleep and Breathing Health, and Residential Care Software. It offers sleep recorders for the diagnosis and titration of sleep apnea in sleep clinics, hospitals, and at home, including ApneaLink Air, a portable diagnostic device that measures oximetry, respiratory effort, pulse, nasal flow, and snoring...

• Industry: Electromedical and Electrotherapeutic Apparatus
• Founded: 1989
• Employees: 10,600
• Stock Exchange: Frankfurt Stock Exchange
• Ticker Symbol: RMEA

Financial Performance

In 2025, ResMed's revenue was $5.15 billion, an increase of 9.84% compared to the previous year's $4.69 billion. Earnings were $1.40 billion, an increase of 37.20%.

Financial numbers in USD